S Jelić
Impact in
-
- Pancreatic and Hepatic Oncology Research
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Celiac Disease Research and Management 3
- Genetics 7
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Stefano CascinuVincenzo ValentiniMassimo FalconiNicholas PavlidisRoger StuppVesna JovanovićNada BabovićSiniša Radulović
In The Last Decade
S Jelić
36 papers receiving 431 citations
Peers
Comparison fields: 5 of 77
- Oncology 225
- Cancer Research 91
- Hepatology 46
- Genetics 55
- Pathology and Forensic Medicine 85
Countries citing papers authored by S Jelić
This map shows the geographic impact of S Jelić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Jelić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Jelić more than expected).
Fields of papers citing papers by S Jelić
This network shows the impact of papers produced by S Jelić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Jelić. The network helps show where S Jelić may publish in the future.
Co-authors
The 25 scholars most cited alongside S Jelić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Significance of tumor burden, vascular endothelial growth factor, lactate dehydrogenase and beta-2 microglobulin serum levels in advanced diffuse large B cell lymphoma. | 2012 | 14 |
| 2 | 2010 | 133 | |
| 3 | Brain metastases as late breast cancer relapse. Single institution experience and review of the literature. | 2009 | 1 |
| 4 | 2009 | 47 | |
| 5 | 2009 | 29 | |
| 6 | 2009 | 4 | |
| 7 | 2009 | 2 | |
| 8 | 2009 | 11 | |
| 9 | 2008 | 4 | |
| 10 | 2006 | 13 | |
| 11 | 2005 | 9 | |
| 12 | 2005 | 2 | |
| 13 | 2005 | 51 | |
| 14 | Non-Hodgkin's lymphomas with primary localization in large bowel and rectum. | 2001 | 5 |
| 15 | Comparison of two non-anthracycline-containing regimens for elderly patients with diffuse large-cell non Hodgkin's lymphoma--possible pitfalls in results reporting and interpretation. | 1999 | 4 |
| 16 | Richter syndrome with emphasis on large-cell non-Hodgkin lymphoma in previously unrecognized subclinical chronic lymphocytic leukemia. | 1997 | 8 |
| 17 | Androgen level variations, clinical response to LHRH agonists and changes in the quality of life subscales in metastatic prostate cancer--speculations about possible role of the monoamine system. | 1997 | 10 |
| 18 | 1994 | 4 | |
| 19 | 1988 | 2 | |
| 20 | [Localized heat urticaria]. | 1978 | 1 |
About S Jelić
S Jelić is a scholar working on Gastroenterology, Genetics, Oncology, Pathology and Forensic Medicine and Otorhinolaryngology, having authored 38 papers that have together received 443 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Cancer Treatment and Pharmacology (7 papers), Chronic Lymphocytic Leukemia Research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Celiac Disease Research and Management (3 papers), Gastric Cancer Management and Outcomes (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Oncology (225 citations), Cancer Research (91 citations), Hepatology (46 citations), Genetics (55 citations) and Pathology and Forensic Medicine (85 citations). S Jelić has collaborated with scholars based in Serbia, Argentina and Hungary. Frequent co-authors include Stefano Cascinu, Vincenzo Valentini, Massimo Falconi, Nicholas Pavlidis, Roger Stupp, Vesna Jovanović, Nada Babović, Siniša Radulović, I Popov and Suzana Matković. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Oncology, BMC Immunology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.